This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Save the date!
November 6–8, 2023Munich, Germany

Catello Somma
Associate at TVM Capital


Catello Somma joined the TVM Capital Life Science team in January 2020 as associate. In this function, he focuses on deal sourcing, investment due diligence, and strategic positioning of portfolio companies.

His involvement is across funds and pillars of the investment thesis.

Through his previous roles within clinical and corporate development in Oncology, Immunology, Cardiovascular, Metabolic and Rare diseases, he is actively contributing with his expertise to driving and supporting new and existing investments in these areas.

Catello currently serves as a board observer for Sarkana, InflammatoRx, T7, Access Vascular and Egg medical.

Before joining TVM, Catello co-founded a Boston VC-baked biotech start-up, developing therapeutics for oncology and autoimmune diseases.

Catello holds an MSc in Molecular biology from the University of Naples and an MBA from Polytechnic University of Milan.

Agenda Sessions

  • In collaboration with YVC Collective - Fireside Chat